Clinical Trial

Thermal Imaging to Evaluate Skin Toxicity from Radiotherapy

Study Description

Thermal Imaging to Evaluate Skin Toxicity From Radiotherapy

A significant proportion of patients treated with whole-breast or head and neck radiotherapy will experience skin toxicity, i.e. skin dermatitis, which may lead to erythema, dry desquamation and wet desquamation. It is hypothesized that quantitative thermal imaging can be used to measure radiation-induced skin toxicity.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Diagnostic Test - Thermography

Thermograms will be acquired of both treated and non-treated cancer site for comparison.

Additional Information

Official Study Title

Quantitative Thermal Imaging to Evaluate Skin Toxicity From Radiation Treatment

Clinical Trial ID

NCT04013711

ParticipAid ID

e0RnLb